Baracaldo-SantamarÃa, D.; Ariza-Salamanca, D.F.; Corrales-Hernández, M.G.; Pachón-Londoño, M.J.; Hernandez-Duarte, I.; Calderon-Ospina, C.-A.
Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside. Pharmaceutics 2022, 14, 152.
https://doi.org/10.3390/pharmaceutics14010152
AMA Style
Baracaldo-SantamarÃa D, Ariza-Salamanca DF, Corrales-Hernández MG, Pachón-Londoño MJ, Hernandez-Duarte I, Calderon-Ospina C-A.
Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside. Pharmaceutics. 2022; 14(1):152.
https://doi.org/10.3390/pharmaceutics14010152
Chicago/Turabian Style
Baracaldo-SantamarÃa, Daniela, Daniel Felipe Ariza-Salamanca, MarÃa Gabriela Corrales-Hernández, Maria José Pachón-Londoño, Isabella Hernandez-Duarte, and Carlos-Alberto Calderon-Ospina.
2022. "Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside" Pharmaceutics 14, no. 1: 152.
https://doi.org/10.3390/pharmaceutics14010152
APA Style
Baracaldo-SantamarÃa, D., Ariza-Salamanca, D. F., Corrales-Hernández, M. G., Pachón-Londoño, M. J., Hernandez-Duarte, I., & Calderon-Ospina, C.-A.
(2022). Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside. Pharmaceutics, 14(1), 152.
https://doi.org/10.3390/pharmaceutics14010152